From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
- Sep 2, 2023
- 1 min
MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
- Jun 29, 2022
- 10 min
Over One Hundred Years of MDMA Research
- Jun 8, 2022
- 5 min
The Post COVID cathinone hydra
- Nov 13, 2021
- 2 min
Psychedelic Harm Reduction Workshop - Student Psychedelic Conference
- Oct 23, 2021
- 4 min
Effects of Mixing and Dosing MDMA, LSD, and 2C-B with Dr Friederike Meckel Fischer
- Sep 14, 2021
- 2 min
Ask the experts: Psilocybin and MDMA Research
- Aug 2, 2021
- 2 min
Emergency Medical Treatment for Adverse Effects of Drugs
- Apr 5, 2021
- 2 min
MDMA for Alcohol Use Disorder
- Mar 29, 2021
- 2 min
Women in Psychedelic Science - Part 3
- Jul 14, 2020
- 2 min
Medical MDMA Educational Resources
- Jun 19, 2020
- 2 min
Launch of the Medical Psychedelics Working Group
- Jul 22, 2019
- 2 min
First safety study of MDMA-assisted psychotherapy in patients with alcohol use disorder
- May 3, 2019
- 2 min
Variability in content of MDMA tablets collected in the UK between 2001 and 2018 - a potential risk to users?
- Jul 24, 2018
- 2 min
Are the neurocognitive deficits associated with MDMA caused by statistical deficits in ecstasy research? A systematic review
- Apr 11, 2018
- 1 min
The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)
- Nov 5, 2017
- 5 min
My dead daughter's shoes
- May 29, 2017
- 1 min
Specific harm reduction strategies employed by MDMA/ecstasy users in the United States and the United Kingdom
- Feb 5, 2017
- 8 min
Recreational MDMA testing - a European perspective
- Sep 10, 2016
- 3 min
I blame Fabric’s closure on this country’s backward drugs policy
- Mar 24, 2015
- 1 min
Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary